We found that survival was not affected in R26+/AIDCd19+/cre compared to R26+/+Cd19+/cre mice (Fig 2A, left) and that lymphoma incidence was not increased in R26+/AIDCd19+/cre mice (Fig 2A, right, and not shown). This evidence concerns the gene CD19 and lymphoma.